---
document_datetime: 2023-09-21 18:00:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rivastigmine-3m-health-care-ltd-epar-all-authorised-presentations_en.pdf
document_name: rivastigmine-3m-health-care-ltd-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.6705593
conversion_datetime: 2025-12-15 21:14:18.550038
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented)name                   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging                            | Pack size   |
|------------------|----------------------------------|------------|-----------------------|---------------------------|------------------------------------------------|-------------|
| EU/1/14/911/001  | Rivastigmine 3M Health Care Ltd. | 4.6 mg/24h | Transdermal patch     | Transdermal use           | pouch (paper/foil/Barex ® laminate)            | 7 pouches   |
| EU/1/14/911/002  | Rivastigmine 3M Health Care Ltd. | 4.6 mg/24h | Transdermal patch     | Transdermal use           | pouch (paper/foil/Barex ® laminate) authorised | 30 pouches  |
| EU/1/14/911/003  | Rivastigmine 3M Health Care Ltd. | 4.6 mg/24h | Transdermal patch     | Transdermal use           | pouch (paper/foil/Barex ® laminate)            | 60 pouches  |
| EU/1/14/911/004  | Rivastigmine 3M Health Care Ltd. | 4.6 mg/24h | Transdermal patch     | Transdermal use longer    | pouch (paper/foil/Barex ® laminate)            | 90 pouches  |
| EU/1/14/911/005  | Rivastigmine 3M Health Care Ltd. | 9.5 mg/24h | Transdermal patch     | Transdermal use           | pouch (paper/foil/Barex ® laminate)            | 7 pouches   |
| EU/1/14/911/006  | Rivastigmine 3M Health Care Ltd. | 9.5 mg/24h | Transdermal patch no  | Transdermal use           | pouch (paper/foil/Barex ® laminate)            | 30 pouches  |
| EU/1/14/911/007  | Rivastigmine 3M Health Care Ltd. | 9.5 mg/24h | Transdermal patch     | Transdermal use           | pouch (paper/foil/Barex ® laminate)            | 60 pouches  |
| EU/1/14/911/008  | Rivastigmine 3M Health Care Ltd. | 9.5 mg/24h | Transdermal Patch     | Transdermal use           | pouch (paper/foil/Barex ® laminate)            | 90 pouches  |

Medicinal product no longer authorised